Clinical Usefulness of 99mTc-HYNIC-TOC and 131I-MIBG Scintigraphy in the Evaluation of Adrenal Tumors

Clinical Usefulness of 99mTc-HYNIC-TOC and 131I-MIBG Scintigraphy in the Evaluation of Adrenal Tumors

Disorders and morphological abnormalities affecting the adrenal gland, could lead to profound clinical consequences, owing to its biochemical structure-activity and morphological characteristics.

Bibliographic Details
Main Authors:	Vukomanovic Vladimir, Matovic Milovan, Djukic Aleksandar, Ignjatovic Vesna, Djukic Svetlana, Vukomanovic Ivana Simic
Format:	Article
Language:	English
Published:	Sciendo 2019-09-01
Series:	Serbian Journal of Experimental and Clinical Research
Subjects:	131i-mibg 99mtc-hynic-toc adrenal tumors
Online Access:	https://doi.org/10.2478/sjecr-2018-0007

Similar Items

99mTc-Hynic-TOC imaging in the diagnostic of neuroendocrine tumors
by: Knut Liepe, et al.
Published: (2018-01-01)

Anatomic Patterns of Relapse and Progression Following Treatment with 131I-MIBG in Metastatic Neuroblastoma
by: Fishel Ben-Kenan, Rotem
Published: (2018)

Radioterapia interna con metayodobencilguanidina 131I-MIBG
by: Harold Machado, et al.
Published: (2002-07-01)

Value of Somatostatin Receptor Scintigraphy with <sup>99m</sup>Tc-HYNIC-TOC in Patients with Primary Sjögren Syndrome
by: Luz Kelly Anzola, et al.
Published: (2019-05-01)

Clinical utility of indigenously formulated single-vial lyophilized HYNIC-TOC kit in evaluating Gastro-entero Pancreatic neuro endocrine tumours
by: Ajit S Shinto, et al.
Published: (2014-05-01)

99mTc-HYNIC-IL-2 scintigraphy to detect acute rejection in lung transplantation patients: a proof-of-concept study
by: Eef D. Telenga, et al.
Published: (2019-05-01)

Cardiac 131I-MIBG scintigraphy in patients with multiple system atrophy
by: Li WANG, et al.
Published: (2014-03-01)

Patient-specific dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in children
by: Xinchi Hou, et al.
Published: (2017-10-01)

Evaluation of 99mTc-HYNIC-βAla-Bombesin(7-14) as an agent for pancreas tumor detection in mice
by: F.N. Carlesso, et al.
Published: (2015-01-01)

99mTc-HYNIC-Annexin A5 in Oncology: Evaluating Efficacy of Anti-Cancer Therapies
by: Chris P. Reutelingsperger, et al.
Published: (2013-05-01)

Utility of 99m Tc-Hynic-TOC in 131I Whole-Body Scan Negative Thyroid Cancer Patients with Elevated Serum Thyroglobulin Levels
by: Ajit S Shinto, et al.
Published: (2015-01-01)

A pictoral review on somatostatin receptor scintigraphy in neuroendocrine tumors: The role of multimodality imaging with SRS and GLUT receptor imaging with FDG PET-CT
by: Sneha Shah, et al.
Published: (2012-10-01)

Upfront consolidation treatment with 131I‐mIbG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high‐risk neuroblastoma
by: Jianhua Feng, et al.
Published: (2020-09-01)

Neuroendocrine tumors treatment with I-131 Metaiodobenzylguanidine (MIBG)
by: Armaghan Fard-fahani, et al.
Published: (2011-09-01)

Radiolabeling of Herceptin with 99mTc as a Her2 tracer
by: Samira Heydari, et al.
Published: (2014-08-01)

Does I-131-MIBG underestimate skeletal disease burden in neuroblastoma?
by: Barai Sukanta, et al.
Published: (2004-10-01)

Uptake and Exposure Measurements in Health Physics Technicians Associated with 131I-MIBG Patient Therapy
by: Collier, Jason L.
Published: (2016)

EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours
by: Jonathan Gear, et al.
Published: (2020-03-01)

99mTc-HYNIC-DAPI-DNA-Bindungsnachweis und Nachweis von DNA-Doppelstrangbrüchen durch 99mTc-HYNIC-DAPI mittels Agarose-Gelelektrophorese
by: Punzet, Robert
Published: (2014)

68Ga-DOTATATE PET/CT Compared with 131I-MIBG SPECT/CT in the Evaluation of Neural Crest Tumors
by: Pezhman Shahrokhi, et al.
Published: (2020-01-01)

Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of <sup>131</sup>I-MIBG
by: Ezziddin Samer, et al.
Published: (2012-01-01)

The significance of metaiodobenzylguanidine scintigraphy in the treatment of high risk neuroblastomas
by: Nikolić Katarina, et al.
Published: (2020-01-01)

Unusual presentation of bladder paraganglioma: Comparison of 131I MIBG SPECT/CT and 68Ga DOTANOC PET/CT
by: Tarun Kumar Jain, et al.
Published: (2016-01-01)

Somatostatin Receptor Scintigraphy in Localization of Pancreatic Neuroendocrine Tumors: A Preliminary Study
by: Pawana Pusuwan, et al.
Published: (2020-07-01)

131I-MIBG and neuroendocrine tumours
by: Juan Perfecto Oliva González, et al.
Published: (2012-07-01)

Investigação de metástases não funcionantes em câncer de tireóide com sestamibi-99mTc e iodo-131: avaliação metodológica comparativa
by: Gonçalves, Mônica Carboni Pereira [UNESP]
Published: (2014)

Targeted Radionuclide Therapy for Patients with Metastatic Pheochromocytoma and Paraganglioma: From Low-Specific-Activity to High-Specific-Activity Iodine-131 Metaiodobenzylguanidine
by: Camilo Jimenez, et al.
Published: (2019-07-01)

Diagnostic Use of Post-therapy <sup>131</sup>I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma
by: Hiroshi Wakabayashi, et al.
Published: (2020-09-01)

Potential Utility of 123I-MIBG Scintigraphy as a Predictor of Falls in Parkinson's Disease
by: Nagahisa Murakami, et al.
Published: (2019-04-01)

Values of 99mTc-methoxyisobutylisonitrile imaging after first-time large-dose 131I therapy in treating differentiated thyroid cancer
by: Pan X, et al.
Published: (2016-02-01)

Low-dose, low-specific activity 131I-metaiodobenzyl guanidine therapy in metastatic pheochromocytoma/sympathetic paraganglioma: Single-center experience from Western India
by: Rohit Barnabas, et al.
Published: (2021-01-01)

Thyroidal radioisotope uptake in euthyroid cats : a comparison between 131I and 99MTcO4
by: N. Lambrechts, et al.
Published: (1997-07-01)

Preparo do reagente liofilizado HYNIC-[Tyr3]-Octreotato e estudo de marcação com Tecnécio-99m
by: Ivani Bortoleti Melo
Published: (2008)

Preparo do reagente liofilizado HYNIC-[Tyr3]-Octreotato e estudo de marcação com Tecnécio-99m
by: Melo, Ivani Bortoleti
Published: (2008)

Preparation and Bioevaluation of Novel <sup>99m</sup>Tc-Labeled Complexes with a 2-Nitroimidazole HYNIC Derivative for Imaging Tumor Hypoxia
by: Qing Ruan, et al.
Published: (2021-02-01)

MIBG Therapy for Neuroblastoma: Precision Achieved With Dosimetry, and Concern for False Responders
by: Pedro M. Rubio, et al.
Published: (2020-05-01)

The role of 99mTc-MIBI SPECT/CT in patients with secondary hyperparathyroidism: comparison with 99mTc-MIBI planar scintigraphy and ultrasonography
by: Shu-Qin Jiang, et al.
Published: (2020-10-01)

Comparison of 99mTc-DMSA, 99mTc-DTPA and 99mTc-MAG3 Renal Scintigraphy in the Calculation of Relative Renal Function
by: Fadime Demir, et al.
Published: (2020-06-01)

“In-house” preparation of 99mTc-EDDA/HYNIC-TOC, a specific targeting agent for somatostatin receptor scintigraphy
by: Sonja Kuzmanovska, et al.
Published: (2012-01-01)

Thyroid uptake and scintigraphy using 99mTc pertechnetate: standardization in normal individuals
by: Celso Darío Ramos, et al.